Last 7 days
-0.6%
Last 30 days
27.3%
Last 90 days
56.9%
Trailing 12 Months
43.6%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 124.2B | 26.3B | -2.34% | 1.62% | 18.96 | 4.72 | 1.32% | 11.18% |
GILD | 98.0B | 27.3B | -7.18% | 37.83% | 21.33 | 3.59 | -0.09% | -26.23% |
MRNA | 57.1B | 19.3B | -7.28% | -16.95% | 6.83 | 2.97 | 4.29% | -31.47% |
BIIB | 38.1B | 10.2B | -3.01% | 25.82% | 12.5 | 3.74 | -7.36% | 95.80% |
MID-CAP | ||||||||
NBIX | 9.2B | 1.5B | -6.54% | 2.94% | 59.61 | 6.19 | 31.34% | 72.43% |
DNLI | 3.1B | 108.5M | -20.63% | -31.77% | -9.51 | 28.59 | 122.90% | -12.19% |
BEAM | 2.2B | 60.9M | -22.54% | -46.32% | -7.52 | 35.66 | 17.51% | 22.00% |
BBIO | 1.9B | 107.9M | 7.80% | 19.42% | -3.99 | 17.93 | 54.84% | 17.36% |
SMALL-CAP | ||||||||
RCUS | 1.2B | 112.0M | -12.49% | -50.70% | -4.44 | 10.58 | -70.76% | -603.77% |
REPL | 1.1B | 7.0M | -19.12% | 19.58% | -7.01 | 156.87 | 131.81% | -45.39% |
FATE | 507.9M | 96.3M | -13.43% | -85.87% | -1.8 | 5.27 | 72.44% | -32.79% |
NVAX | 499.9M | 2.0B | -38.13% | -92.75% | -0.76 | 0.25 | 72.89% | 62.27% |
SGMO | 278.5M | 111.3M | -41.20% | -71.01% | -1.45 | 2.5 | 0.54% | -7.86% |
VXRT | 98.0M | 107.0K | -22.42% | -85.54% | -0.91 | 915.57 | -88.00% | -52.91% |
IBIO | 26.6M | - | 29.52% | -80.89% | -0.33 | 3.21 | 0.51% | -185.61% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 5.3% | 1,962,412,000 | 1,864,113,000 | 1,777,873,000 | 1,668,849,000 | 1,574,371,000 |
S&GA Expenses | 0.6% | 820,963,000 | 815,799,000 | 785,702,000 | 730,573,000 | 716,190,000 |
R&D Expenses | 4.1% | 1,344,361,000 | 1,290,812,000 | 1,365,299,000 | 1,295,906,000 | 1,228,672,000 |
Costs and Expenses | 3.2% | 2,575,382,000 | 2,495,149,000 | 2,514,067,000 | 2,361,535,000 | 2,256,427,000 |
EBITDA | 5.6% | -555,588,000 | -588,369,000 | -693,551,000 | -644,806,000 | - |
EBITDA Margin | 10.3% | -0.28 | -0.32 | -0.39 | -0.39 | - |
Earnings Before Taxes | 5.2% | -602,315,000 | -635,461,000 | -739,669,000 | -689,525,000 | -675,705,000 |
EBT Margin | 10.0% | -0.31 | -0.34 | -0.42 | -0.41 | - |
Net Income | 4.2% | -610,308,000 | -636,765,000 | -739,796,000 | -689,545,000 | -674,471,000 |
Net Income Margin | 9.0% | -0.31 | -0.34 | -0.42 | -0.41 | - |
Free Cahsflow | 26.2% | -531,091,000 | -719,364,000 | -651,907,000 | -652,705,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 1.5% | 3,675 | 3,619 | 3,630 | 3,617 | 3,720 |
Current Assets | 1.6% | 2,803 | 2,760 | 2,779 | 2,771 | 2,869 |
Cash Equivalents | -11.8% | 320 | 363 | 365 | 261 | 425 |
Inventory | 17.1% | 427 | 365 | 319 | 276 | 201 |
Net PPE | 7.8% | 248 | 230 | 219 | 214 | 210 |
Goodwill | 0% | 275 | 275 | 275 | 275 | 275 |
Current Liabilities | 12.7% | 818 | 726 | 609 | 531 | 569 |
Shareholder's Equity | -0.6% | 2,804 | 2,822 | 2,933 | 2,998 | 3,065 |
Retained Earnings | -7.4% | -2,154 | -2,006 | -1,815 | -1,680 | -1,544 |
Additional Paid-In Capital | 2.7% | 4,954 | 4,825 | 4,747 | 4,678 | 4,608 |
Accumulated Depreciation | - | 212 | - | - | - | - |
Shares Outstanding | 0.7% | 187 | 185 | 184 | 184 | 183 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 31.0% | -453 | -657 | -589 | -590 | -499 |
Share Based Compensation | 5.8% | 221 | 209 | 195 | 179 | 173 |
Cashflow From Investing | -14.1% | 228 | 266 | 469 | 394 | 289 |
Cashflow From Financing | 52.2% | 125 | 82.00 | 86.00 | 85.00 | 78.00 |
72.3%
55.4%
0%
Y-axis is the maximum loss one would have experienced if Seagen was unfortunately bought at previous high price.
18.6%
28.4%
31.4%
26.2%
FIve years rolling returns for Seagen.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -2.97 | -1,651,330 | 16,957,700 | 0.02% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | -1,551 | 16,449 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 37.31 | 36,000 | 162,000 | -% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | unchanged | - | -22,598 | 353,402 | 0.02% |
2023-02-28 | Voya Investment Management LLC | added | 19.01 | 9,900,110 | 93,952,100 | 0.13% |
2023-02-27 | Parallax Volatility Advisers, L.P. | new | - | 435,006 | 435,006 | -% |
2023-02-24 | BBJS FINANCIAL ADVISORS, LLC | new | - | 12,851 | 12,851 | 0.01% |
2023-02-24 | National Pension Service | added | 9.34 | 906,189 | 26,488,400 | 0.05% |
2023-02-24 | Garde Capital, Inc. | unchanged | - | -12,000 | 186,000 | 0.02% |
2023-02-24 | NATIXIS | added | 396 | 2,685,390 | 3,419,390 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Mar 13, 2023 | baker bros. advisors lp | 25.1% | 46,985,656 | SC 13D/A | |
Feb 13, 2023 | capital international investors | 9.7% | 18,058,081 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 6.97% | 12,945,078 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.32% | 9,881,292 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.4% | 11,861,464 | SC 13G/A | |
Mar 10, 2022 | baker bros. advisors lp | 25.6% | 46,975,613 | SC 13D/A | |
Feb 11, 2022 | capital international investors | 7.0% | 12,778,429 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 6.36% | 11,629,729 | SC 13G | |
Feb 01, 2022 | blackrock inc. | 7.3% | 13,341,753 | SC 13G/A | |
May 18, 2021 | baker bros. advisors lp | 26.1% | 47,370,508 | SC 13D/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 6.67 -96.65% | 10.88 -94.54% | 16.92 -91.51% | 23.73 -88.09% | 31.02 -84.43% |
Current Inflation | 6.07 -96.95% | 9.73 -95.12% | 14.82 -92.56% | 20.52 -89.70% | 26.64 -86.63% |
Very High Inflation | 5.34 -97.32% | 8.34 -95.81% | 12.36 -93.80% | 16.81 -91.56% | 21.60 -89.16% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 17, 2023 | 4 | Insider Trading | |
Mar 16, 2023 | 4 | Insider Trading | |
Mar 13, 2023 | DEFA14A | DEFA14A | |
Mar 13, 2023 | SC 13D/A | 13D - Major Acquisition | |
Mar 13, 2023 | DEFA14A | DEFA14A | |
Mar 13, 2023 | DEFA14A | DEFA14A | |
Mar 13, 2023 | DEFA14A | DEFA14A | |
Mar 13, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-16 | LIU JEAN I | acquired | 195,750 | 39.15 | 5,000 | chief legal officer |
2023-03-16 | LIU JEAN I | sold | -999,500 | 199 | -5,000 | chief legal officer |
2023-03-15 | DANSEY ROGER D | sold | -1,998,120 | 199 | -10,000 | president, r&d & cmo |
2023-03-15 | WELCH DANIEL G | sold | -249,262 | 200 | -1,246 | - |
2023-03-15 | WELCH DANIEL G | acquired | 79,076 | 38.82 | 2,037 | - |
2023-03-15 | WELCH DANIEL G | sold | -471,518 | 200 | -2,357 | - |
2023-03-15 | DANSEY ROGER D | acquired | 726,400 | 72.64 | 10,000 | president, r&d & cmo |
2023-03-14 | WELCH DANIEL G | sold | -57,600 | 200 | -288 | - |
2023-03-14 | WELCH DANIEL G | sold | -108,800 | 200 | -544 | - |
2023-03-14 | WELCH DANIEL G | acquired | 18,245 | 38.82 | 470 | - |
Consolidated Statements of Comprehensive (Loss) Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Revenue | $ 1,962,412 | $ 1,574,371 | $ 2,175,536 |
Costs and expenses: | |||
Cost of sales | 410,058 | 311,565 | 217,720 |
Research and development | 1,344,361 | 1,228,672 | 827,129 |
Selling, general and administrative | 820,963 | 716,190 | 533,835 |
Total costs and expenses | 2,575,382 | 2,256,427 | 1,578,684 |
(Loss) income from operations | (612,970) | (682,056) | 596,852 |
Investment and other income, net | 10,655 | 6,351 | 18,849 |
(Loss) income before income taxes | (602,315) | (675,705) | 615,701 |
Provision (benefit) for income taxes | 7,993 | (1,234) | 2,031 |
Net (loss) income | $ (610,308) | $ (674,471) | $ 613,670 |
Net (loss) income per share - basic (in dollars per share) | $ (3.30) | $ (3.70) | $ 3.51 |
Net (loss) income per share - diluted (in dollars per share) | $ (3.30) | $ (3.70) | $ 3.37 |
Shares used in computation of per share amounts - basic (in shares) | 184,676 | 182,048 | 174,834 |
Shares used in computation of per share amounts - diluted (in shares) | 184,676 | 182,048 | 182,287 |
Comprehensive (loss) income: | |||
Net (loss) income | $ (610,308) | $ (674,471) | $ 613,670 |
Other comprehensive income: | |||
Unrealized loss on securities available-for-sale, net of income tax provision of $0, $0, and $0, respectively | (1,401) | (211) | (186) |
Foreign currency translation gain, net of income tax provision of $0, $0, and $0, respectively | 3,732 | 825 | 522 |
Total other comprehensive income | 2,331 | 614 | 336 |
Comprehensive (loss) income | (607,977) | (673,857) | 614,006 |
Net product sales | |||
Revenues: | |||
Revenue | 1,706,516 | 1,385,566 | 1,000,598 |
Royalty revenues | |||
Revenues: | |||
Revenue | 164,554 | 150,523 | 126,756 |
Collaboration and license agreement revenues | |||
Revenues: | |||
Revenue | $ 91,342 | $ 38,282 | $ 1,048,182 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 319,940 | $ 424,834 |
Short-term investments | 1,415,130 | 1,735,202 |
Accounts receivable, net | 501,912 | 389,256 |
Inventories | 427,211 | 200,663 |
Prepaid expenses and other current assets | 138,340 | 119,239 |
Total current assets | 2,802,533 | 2,869,194 |
Property and equipment, net | 248,179 | 210,073 |
Operating lease right-of-use assets | 46,738 | 57,889 |
Intangible assets, net | 237,516 | 260,593 |
Goodwill | 274,671 | 274,671 |
Other non-current assets | 64,895 | 47,184 |
Total assets | 3,674,532 | 3,719,604 |
Current liabilities: | ||
Accounts payable | 207,851 | 114,824 |
Accrued liabilities and other | 610,553 | 454,030 |
Total current liabilities | 818,404 | 568,854 |
Long-term liabilities: | ||
Operating lease liabilities, long-term | 43,474 | 56,665 |
Other long-term liabilities | 8,835 | 28,946 |
Total long-term liabilities | 52,309 | 85,611 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued | 0 | 0 |
Common stock, $0.001 par value, 250,000 shares authorized; 186,559 shares issued and outstanding at December 31, 2022 and 183,381 shares issued and outstanding at December 31, 2021 | 187 | 183 |
Additional paid-in capital | 4,954,469 | 4,607,816 |
Accumulated other comprehensive income | 3,510 | 1,179 |
Accumulated deficit | (2,154,347) | (1,544,039) |
Total stockholders' equity | 2,803,819 | 3,065,139 |
Total liabilities and stockholders' equity | $ 3,674,532 | $ 3,719,604 |